Facility Limitation Considerations for Filling Pandemic Vaccine

  • Share:

Specifications for Manufacturers to Prepare to Produce Billions of Doses of COVID-19 Vaccine

Dosage: Multidose vs unit dose, preservative for multi-dose.

Container Type: Viral, syringe, nasal presentation.

Fill Volume: Overage, headspace considerations.

Fill Speed: Based upon vaccine attributes (viscosity, thermal stability, liquid consistency).

Existing Equipment Capability: Hold-up volume, capacity, change parts availability.

Final Product Form: Is the final form a liquid or powder requiring reconstitution with diluent?

In addition to clinical trials and test results that require FDA approval for efficacy of the vaccine, these tactical considerations must be addressed to bring the vaccine to market.

  • Share:

Explore Solutions

Let’s Get Started

Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.

1.877.787.0177

22320 Foothill Blvd. Suite 330, Hayward CA 94541